Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carroll, A.
Right arrow Articles by Phillips, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carroll, A.
Right arrow Articles by Phillips, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study

A Carroll, C Civin, N Schneider, G Dahl, A Pappo, P Bowman, A Emami, S Gross, C Alvarado and C Phillips

Laboratory of Medical Genetics, University of Alabama, Birmingham.

We report the nonrandom occurrence and frequency of the t(1;22)(p13;q13) in acute myeloid leukemia (AML) and its close association with the French-American-British M7 subtype of AML in infants (less than 1 year). This chromosomal abnormality occurred in 6 of 252 (2.4%) children and adolescents with AML (6 of 28 infants, 22%; 6 of 18 M7 AML cases overall, 33%; and 6 of 6 M7 cases in infants). Infants with AML of M7 subtype and the t(1;22) often presented with prominent abdominal masses. Two of these infants were not treated and died early. Three of four treated infants entered complete remission with therapy for AML; the remaining infant died of hemorrhage on day 8. Of the three infants who entered remission, only one remains alive and disease free at 5+ months. The other two infants relapsed in the bone marrow at 5 and 2 months from the start of therapy, respectively. We conclude that M7 AML with the t(1;22) usually presents in infants with extensive infiltration of abdominal organs by leukemic cells and may confer a poor prognosis despite intensive AML-directed treatment. Identification of this nonrandom translocation exclusively in infants with acute megakaryoblastic leukemia (AMkL) implies that it may serve as an additional diagnostic marker for this disease and links it to the pathogenesis of AMkL in infants.

Volume 78, Issue 3, pp. 748-752, 08/01/1991
Copyright © 1991 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
A. Descot, M. Rex-Haffner, G. Courtois, D. Bluteau, A. Menssen, T. Mercher, O. A. Bernard, R. Treisman, and G. Posern
OTT-MAL Is a Deregulated Activator of Serum Response Factor-Dependent Gene Expression
Mol. Cell. Biol., October 15, 2008; 28(20): 6171 - 6181.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Forestier, S. Izraeli, B. Beverloo, O. Haas, A. Pession, K. Michalova, B. Stark, C. J. Harrison, A. Teigler-Schlegel, and B. Johansson
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study
Blood, February 1, 2008; 111(3): 1575 - 1583.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Ma, M. J. Renda, L. Wang, E.-c. Cheng, C. Niu, S. W. Morris, A. S. Chi, and D. S. Krause
Rbm15 Modulates Notch-Induced Transcriptional Activation and Affects Myeloid Differentiation
Mol. Cell. Biol., April 15, 2007; 27(8): 3056 - 3064.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. D. Raffel, T. Mercher, H. Shigematsu, I. R. Williams, D. E. Cullen, K. Akashi, O. A. Bernard, and D. G. Gilliland
Ott1(Rbm15) has pleiotropic roles in hematopoietic development
PNAS, April 3, 2007; 104(14): 6001 - 6006.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Ge, T. L. Jensen, L. H. Matherly, and J. W. Taub
Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines
Blood, February 15, 2003; 101(4): 1551 - 1557.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Dastugue, M. Lafage-Pochitaloff, M.-P. Pages, I. Radford, C. Bastard, P. Talmant, M. J. Mozziconacci, C. Leonard, C. Bilhou-Nabera, C. Cabrol, et al.
Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Francais de Cytogenetique Hematologique (GFCH)
Blood, June 28, 2002; 100(2): 618 - 626.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. H. Athale, B. I. Razzouk, S. C. Raimondi, X. Tong, F. G. Behm, D. R. Head, D. K. Srivastava, J. E. Rubnitz, L. Bowman, C.-H. Pui, et al.
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience
Blood, June 15, 2001; 97(12): 3727 - 3732.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Mercher, M. B.-L. Coniat, R. Monni, M. Mauchauffe, F. N. Khac, L. Gressin, F. Mugneret, T. Leblanc, N. Dastugue, R. Berger, et al.
Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia
PNAS, May 8, 2001; 98(10): 5776 - 5779.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. S. Tallman, D. Neuberg, J. M. Bennett, C. J. Francois, E. Paietta, P. H. Wiernik, G. Dewald, P. A. Cassileth, M. M. Oken, and J. M. Rowe
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience
Blood, October 1, 2000; 96(7): 2405 - 2411.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1991 by American Society of Hematology         Online ISSN: 1528-0020